John F. Ginascol
2020
Compensation breakdown
Change in Pension Value and Nonqualified Deferred Compensation Earnings | $1,781,066 |
---|---|
Non-Equity Incentive Plan | $857,300 |
Option Awards | $1,653,987 |
Salary | $708,269 |
Stock Awards | $1,653,678 |
Other | $112,729 |
Total | $6,767,029 |
Ginascol received $1.8M of change in pension value and nonqualified deferred compensation earnings, accounting for 26% of the total pay in 2020.
Ginascol also received $857.3K in non-equity incentive plan, $1.7M in option awards, $708.3K in salary, $1.7M in stock awards and $112.7K in other compensation.
Rankings
In 2020, John F. Ginascol's compensation ranked 1,468th out of 13,090 executives tracked by ExecPay. In other words, Ginascol earned more than 88.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,468 | 89th |
Manufacturing | 545 | 90th |
Chemicals And Allied Products | 198 | 91st |
Drugs | 165 | 92nd |
Pharmaceutical Preparations | 115 | 92nd |
Pay ratio
John F. Ginascol's Pay | $6,767,029 |
---|---|
Median Employee's Pay | $77,594 |
Pay Ratio | 87to 1 |
In 2020, the annual total compensation of John F. Ginascol was $6,767,029.
The annual total compensation of the median employee at Abbott Laboratories was $77,594.
The ratio of John F. Ginascol's pay to the pay of median employee was therefore 87 to one.
Ginascol's colleagues
We found six more compensation records of executives who worked with John F. Ginascol at Abbott Laboratories in 2020.
2020
Robert Ford
Abbott Laboratories
Chief Executive Officer
2020
Miles White
Abbott Laboratories
Chairman
2020
Robert Funck
Abbott Laboratories
Chief Financial Officer
2020
Hubert Allen
Abbott Laboratories
General Counsel
2020
Daniel Salvadori
Abbott Laboratories
Executive Vice President, Nutritional Products
2020
Brian Yoor
Abbott Laboratories